These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 35742486)

  • 1. SARS-CoV-2 Risk Quantification Model and Validation Based on Large-Scale Dutch Test Events.
    Kolen B; Znidarsic L; Voss A; Donders S; Kamphorst I; van Rijn M; Bonthuis D; Clocquet M; Schram M; Scharloo R; Boersma T; Stobernack T; van Gelder P
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: A modelling study.
    Teslya A; Pham TM; Godijk NG; Kretzschmar ME; Bootsma MCJ; Rozhnova G
    PLoS Med; 2020 Jul; 17(7):e1003166. PubMed ID: 32692736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Were lockdowns justified? A return to the facts and evidence.
    van Basshuysen P; White L
    Kennedy Inst Ethics J; 2021; 31(4):405-428. PubMed ID: 34897118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Citywide 'Virus Testing': Chinese Government's Response to Preventing and Controlling the Second Outbreak of SARS-CoV-2.
    Zhou L; Seesaghur HN; Akhtar N; Boolakee J; Pratt CB
    Front Public Health; 2021; 9():601592. PubMed ID: 34222164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mini-review on the effects of COVID-19 on younger individuals.
    Manivannan M; Jogalekar MP; Kavitha MS; Maran BAV; Gangadaran P
    Exp Biol Med (Maywood); 2021 Feb; 246(3):293-297. PubMed ID: 33210552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pitfalls of preventive testing for SARS-CoV-2].
    Wismans LV; Fanoy EB; van Eijck CHJ; van der Eijk AA
    Ned Tijdschr Geneeskd; 2020 Dec; 165():. PubMed ID: 33332034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Covid-19 reinfections: what is the clinical relevance?].
    Wiersinga WJ; de Bree GJ
    Ned Tijdschr Geneeskd; 2020 Dec; 164():. PubMed ID: 33332056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Localized Lockdowns in the COVID-19 Pandemic.
    Li Y; Undurraga EA; Zubizarreta JR
    Am J Epidemiol; 2022 Mar; 191(5):812-824. PubMed ID: 35029649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coming together after standing apart: What predicts felt safety in the post-coronavirus crowd?
    Morton TA; Power SA
    Soc Sci Med; 2022 Jan; 293():114649. PubMed ID: 34906827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries.
    Islam N; Sharp SJ; Chowell G; Shabnam S; Kawachi I; Lacey B; Massaro JM; D'Agostino RB; White M
    BMJ; 2020 Jul; 370():m2743. PubMed ID: 32669358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
    Hippisley-Cox J; Patone M; Mei XW; Saatci D; Dixon S; Khunti K; Zaccardi F; Watkinson P; Shankar-Hari M; Doidge J; Harrison DA; Griffin SJ; Sheikh A; Coupland CAC
    BMJ; 2021 Aug; 374():n1931. PubMed ID: 34446426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifting mobility restrictions and the effect of superspreading events on the short-term dynamics of COVID-19.
    Santana-Cibrian M; Acuña-Zegarra MA; Velasco-Hernandez JX
    Math Biosci Eng; 2020 Sep; 17(5):6240-6258. PubMed ID: 33120597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia.
    Enticott J; Gill JS; Bacon SL; Lavoie KL; Epstein DS; Dawadi S; Teede HJ; Boyle J;
    BMJ Open; 2022 Jan; 12(1):e057127. PubMed ID: 34980631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    COVID-19 National Preparedness Collaborators
    Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.